Cargando…

C-Tb skin test to diagnose Mycobacterium tuberculosis infection in children and HIV-infected adults: A phase 3 trial

BACKGROUND: C-Tb, an ESAT-6/CFP-10-based skin test, has similar sensitivity for active TB compared to tuberculin skin test (TST) and QuantiFERON-TB-Gold-In-Tube (QFT). However, data are limited in children and HIV-infected persons. METHODS: Asymptomatic South African contacts <5 years (n = 87; HI...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aggerbeck, Henrik, Ruhwald, Morten, Hoff, Søren T., Borregaard, Bettine, Hellstrom, Elizabeth, Malahleha, Mookho, Siebert, Mirna, Gani, Mashra, Seopela, Vincent, Diacon, Andreas, Lourens, Madeleine, Andersen, Peter, Dheda, Keertan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6152999/ https://www.ncbi.nlm.nih.gov/pubmed/30248152 http://dx.doi.org/10.1371/journal.pone.0204554

Ejemplares similares

Randomised Clinical Trial Investigating the Specificity of a Novel Skin Test (C-Tb) for Diagnosis of M. tuberculosis Infection
por: Aggerbeck, Henrik, et al.
Publicado: (2013)

Evaluating Latent Tuberculosis Infection Test Performance Using Latent Class Analysis in a TB and HIV Endemic Setting
por: Adams, Shahieda, et al.
Publicado: (2019)

Accelerate investment and action to find the missing patients with tuberculosis
por: Dheda, Keertan, et al.
Publicado: (2022)

Selection and Application of ssDNA Aptamers to Detect Active TB from Sputum Samples
por: Rotherham, Lia S., et al.
Publicado: (2012)

Latent Tuberculosis Infection–associated Immunodiagnostic Test Responses as Biomarkers of Incipient Tuberculosis: Fruitful or Futile?
por: Dheda, Keertan, et al.
Publicado: (2020)

Early morning urine collection to improve urinary lateral flow LAM assay sensitivity in hospitalised patients with HIV-TB co-infection
por: Gina, Phindile, et al.
Publicado: (2017)

An Optimal Diagnostic Strategy for Tuberculosis in Hospitalized HIV-Infected Patients Using GeneXpert MTB/RIF and Alere Determine TB LAM Ag
por: Esmail, Aliasgar, et al.
Publicado: (2020)

Association of anti-tuberculosis drug concentrations in hair and treatment outcomes in MDR- and XDR-TB
por: Metcalfe, John, et al.
Publicado: (2019)

Test characteristics and potential impact of the urine LAM lateral flow assay in HIV-infected outpatients under investigation for TB and able to self-expectorate sputum for diagnostic testing
por: Peter, Jonny, et al.
Publicado: (2015)

Integrated testing for TB and COVID-19
por: MacLean, Emily L., et al.
Publicado: (2022)

Can Point-of-Care Urine LAM Strip Testing for Tuberculosis Add Value to Clinical Decision Making in Hospitalised HIV-Infected Persons?
por: Peter, Jonathan G., et al.
Publicado: (2013)

Practical considerations for a TB controlled human infection model (TB-CHIM); the case for TB-CHIM in Africa, a systematic review of the literature and report of 2 workshop discussions in UK and Malawi
por: Gordon, Stephen B., et al.
Publicado: (2023)

Improving T-Cell Assays for the Diagnosis of Latent TB Infection: Potential of a Diagnostic Test Based on IP-10
por: Ruhwald, Morten, et al.
Publicado: (2008)

Diagnosing tuberculosis in hospitalized HIV-infected individuals who cannot produce sputum: is urine lipoarabinomannan testing the answer?
por: Sabur, Natasha F., et al.
Publicado: (2017)

Same-Day Tools, Including Xpert Ultra and IRISA-TB, for Rapid Diagnosis of Pleural Tuberculosis: a Prospective Observational Study
por: Meldau, Richard, et al.
Publicado: (2019)

The diagnostic accuracy of the MTBDRplus and MTBDRsl assays for drug-resistant TB detection when performed on sputum and culture isolates
por: Tomasicchio, Michele, et al.
Publicado: (2016)

Data quality in an HIV vaccine efficacy clinical trial in South Africa: through natural disasters and with discipline
por: Laher, Fatima, et al.
Publicado: (2023)

Introducing the ESAT-6 free IGRA, a companion diagnostic for TB vaccines based on ESAT-6
por: Ruhwald, Morten, et al.
Publicado: (2017)

Determine TB-LAM lateral flow urine antigen assay for HIV-associated tuberculosis: recommendations on the design and reporting of clinical studies
por: Lawn, Stephen D, et al.
Publicado: (2013)

Predictors of discordant latent tuberculosis infection test results amongst South African health care workers
por: Adams, Shahieda, et al.
Publicado: (2019)

Sexually transmitted infections amongst men who have sex with men (MSM) in South Africa
por: Mashingaidze, Rujeko, et al.
Publicado: (2023)

Lung health in Africa: African solutions for African challenges – to infinity and beyond
por: Koegelenberg, Coenie, et al.
Publicado: (2018)

Clinical Utility of a Commercial LAM-ELISA Assay for TB Diagnosis in HIV-Infected Patients Using Urine and Sputum Samples
por: Dheda, Keertan, et al.
Publicado: (2010)

IP-10, MCP-1, MCP-2, MCP-3, and IL-1RA hold promise as biomarkers for infection with M. tuberculosis in a whole blood based T-cell assay
por: Ruhwald, Morten, et al.
Publicado: (2009)

Use of Anti-Retroviral Therapy in Tuberculosis Patients on Second-Line Anti-TB Regimens: A Systematic Review
por: Arentz, Matthew, et al.
Publicado: (2012)

IP-10 Can Be Measured in Dried Plasma Spots in Patients with Chronic Hepatitis C Infection
por: Ruhwald, Morten, et al.
Publicado: (2012)

The Diagnostic Accuracy of Urine-Based Xpert MTB/RIF in HIV-Infected Hospitalized Patients Who Are Smear-Negative or Sputum Scarce
por: Peter, Jonathan G., et al.
Publicado: (2012)

Prevalence of Mycobacterium tuberculosis infection as measured by the QuantiFERON-TB Gold assay and ESAT-6 free IGRA among adolescents in Mwanza, Tanzania
por: Jeremiah, Kidola, et al.
Publicado: (2021)

What is new in the WHO consolidated guidelines on drug-resistant tuberculosis treatment?
por: Sharma, Surendra K., et al.
Publicado: (2019)

Negative effect of smoking on the performance of the QuantiFERON TB gold in tube test
por: Aabye, Martine G, et al.
Publicado: (2012)

Hepatitis B virus reactivation or reinfection in a FEM-PrEP participant: a case report
por: Malahleha, Mookho, et al.
Publicado: (2015)

First-in-Man Open Clinical Trial of a Combined rdESAT-6 and rCFP-10 Tuberculosis Specific Skin Test Reagent
por: Bergstedt, Winnie, et al.
Publicado: (2010)

120. A Randomized Double-blind Trial Assessing the Efficacy of M72/AS01(E) Vaccine Against Pulmonary Tuberculosis Disease in Adults With Latent Mycobacterium tuberculosis Infection
por: Meeren, Olivier Van Der, et al.
Publicado: (2018)

Pretomanid with bedaquiline and linezolid for drug-resistant TB: a comparison of prospective cohorts
por: Oelofse, S., et al.
Publicado: (2021)

Persistently elevated T cell interferon-γ responses after treatment for latent tuberculosis infection among health care workers in India: a preliminary report
por: Pai, Madhukar, et al.
Publicado: (2006)

How are high burden countries implementing policies and tools for latent tuberculosis infection? A survey of current practices and barriers
por: Faust, Lena, et al.
Publicado: (2020)

Do digital innovations for HIV and sexually transmitted infections work? Results from a systematic review (1996-2017)
por: Daher, Jana, et al.
Publicado: (2017)

Development of a One-Step Probe Based Molecular Assay for Rapid Immunodiagnosis of Infection with M. tuberculosis Using Dried Blood Spots
por: Blauenfeldt, Thomas, et al.
Publicado: (2014)

Economic analysis of different throughput scenarios and implementation strategies of computer-aided detection software as a screening and triage test for pulmonary TB
por: Bashir, Saima, et al.
Publicado: (2022)

Performance of the TB-LAMP diagnostic assay in reference laboratories: Results from a multicentre study
por: Pham, Thu Hang, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_b8nc8a5gfnobr1jf9uu9dp5ufl